Literature DB >> 11036127

Treatment of lupus nephritis--a work in progress.

R J Falk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036127     DOI: 10.1056/NEJM200010193431610

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.

Authors:  Meng-Yu Weng; Chia-Tse Weng; Ming-Fei Liu
Journal:  Clin Rheumatol       Date:  2010-03-02       Impact factor: 2.980

2.  Recent advances in immunotherapies for lupus nephritis.

Authors:  Machi Kaneko; Shaun W Jackson
Journal:  Pediatr Nephrol       Date:  2022-07-01       Impact factor: 3.714

Review 3.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

Authors:  Alice S Appel; Gerald B Appel
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

Review 4.  Disparities in lupus care and outcomes.

Authors:  Kristina L Demas; Karen H Costenbader
Journal:  Curr Opin Rheumatol       Date:  2009-03       Impact factor: 5.006

5.  Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.

Authors:  Hanns-Martin Lorenz; Wilhelm H Schmitt; Vladimir Tesar; Ulf Müller-Ladner; Ingo Tarner; Ingeborg A Hauser; Falk Hiepe; Tobias Alexander; Heike Woehling; Kyuichi Nemoto; Peter A Heinzel
Journal:  Arthritis Res Ther       Date:  2011-03-01       Impact factor: 5.156

6.  In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study.

Authors:  Kathan Mehta; Palashkumar Jaiswal; Farren Briggs; William A Faubion; James H Tabibian; Fabio Cominelli; Maneesh Dave
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.